1,109
Views
31
CrossRef citations to date
0
Altmetric
Review

Eradication of human papillomavirus and elimination of HPV-related diseases – scientific basis for global public health policies

, , , &
Pages 153-160 | Received 14 Aug 2018, Accepted 09 Jan 2019, Published online: 07 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Matti Lehtinen, Penelope Gray, Karolina Louvanto & Simopekka Vänskä. (2022) In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers. Expert Review of Vaccines 21:6, pages 735-738.
Read now

Articles from other publishers (30)

Peter L. Stern. (2023) Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia?. Tumour Virus Research 16, pages 200263.
Crossref
Ville N. Pimenoff, Penelope Gray, Karolina Louvanto, Tiina Eriksson, Camilla Lagheden, Anna Söderlund-Strand, Joakim Dillner & Matti Lehtinen. (2023) Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts. Cell Host & Microbe 31:11, pages 1921-1929.e3.
Crossref
Sifon Ndon, Amritpal Singh, Patrick K. Ha, Joyce Aswani, Jason Ying-Kuen Chan & Mary Jue Xu. (2023) Human Papillomavirus-Associated Oropharyngeal Cancer: Global Epidemiology and Public Policy Implications. Cancers 15:16, pages 4080.
Crossref
Filip Tichanek, Asta Försti, Otto Hemminki, Akseli Hemminki & Kari Hemminki. (2023) Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries. Obstetrics and Gynecology International 2023, pages 1-9.
Crossref
Kehinde Kazeem Kanmodi, Eyinade Adeduntan Egbedina, Jimoh Amzat, Kafayat Aminu & Lawrence Achilles Nnyanzi. (2023) The state of human papillomavirus research in Africa. Public Health Challenges 2:1.
Crossref
J. Andrew Dykens, Caryn E. Peterson, Hunter K. Holt & Diane M. Harper. (2023) Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally. Frontiers in Public Health 11.
Crossref
Mi Zeng, Xin Li, Xiaoyang Jiao, Xiaochun Cai, Fen Yao, Shaomin Xu, Xiaoshan Huang, Qiaoxin Zhang & Jianqiang Chen. (2023) Roles of vaginal flora in human papillomavirus infection, virus persistence and clearance. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Kari Hemminki, Anna Kanerva, Asta Försti & Akseli Hemminki. (2022) Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment. BMC Cancer 22:1.
Crossref
Kangni Zou, Yue Huang & Zhengyu Li. (2022) Prevention and treatment of human papillomavirus in men benefits both men and women. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Jingying Wang, Qi Wang, Pingjiao Chen, Qian Li, Zhijia Li, Meinian Xu, Kang Zeng & Changxing Li. (2021) Podophyllotoxin‐combined 5‐aminolevulinic acid photodynamic therapy significantly promotes HR‐HPV‐infected cell death. Photodermatology, Photoimmunology & Photomedicine 38:4, pages 343-353.
Crossref
Francesco DI PIERRO, Anna A. CRISCUOLO, Anna DEI GIUDICI, Roberto SENATORI, Francesco SESTI, Marco CIOTTI & Emilio PICCIONE. (2021) Oral administration of Lactobacillus crispatus M247 to papillomavirus-infected women: results of a preliminary, uncontrolled, open trial. Minerva Obstetrics and Gynecology 73:5.
Crossref
Ruth Tachezy & Jana Šmahelová. (2021) Why to vaccinate boys against papillomaviruses?. Pediatrie pro praxi 22:4, pages 263-267.
Crossref
Rosa De Vincenzo, Nicola Caporale, Valentina Bertoldo, Caterina Ricci, Maria Teresa Evangelista, Nicolò Bizzarri, Luigi Pedone Anchora, Giovanni Scambia & Giovanni Capelli. (2021) HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study. Vaccines 9:6, pages 643.
Crossref
Cintia Muñoz-Quiles, Javier Díez-Domingo, Luis Acedo, Víctor Sánchez-Alonso & Rafael J. Villanueva. (2021) On the Elimination of Infections Related to Oncogenic Human Papillomavirus: An Approach Using a Computational Network Model. Viruses 13:5, pages 906.
Crossref
Laia Bruni, Anna Saura-Lázaro, Alexandra Montoliu, Maria Brotons, Laia Alemany, Mamadou Saliou Diallo, Oya Zeren Afsar, D. Scott LaMontagne, Liudmila Mosina, Marcela Contreras, Martha Velandia-González, Roberta Pastore, Marta Gacic-Dobo & Paul Bloem. (2021) HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019. Preventive Medicine 144, pages 106399.
Crossref
Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, María Garcés-Sánchez, Nuria García Sánchez, Elisa Garrote Llanos, Ángel Hernández Merino, Antonio Iofrío de Arce, Abián Montesdeoca Melián, María Luisa Navarro Gómez & Jesús Ruiz-Contreras. (2021) Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations. Anales de Pediatría (English Edition) 94:1, pages 53.e1-53.e10.
Crossref
R. L. O. van de Laar, W. Hofhuis, R. G. Duijnhoven, S. Polinder, W. J. G. Melchers, F. J. van Kemenade, R. L. M. Bekkers & H. J. Van Beekhuizen. (2020) Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial. BMC Cancer 20:1.
Crossref
Walter E.P. Beyer & Albert D.M.E. Osterhaus. (2020) Bivalent AS04-adjuvanted HPV vaccine provides optimal cancer prevention for HPV types not included in the vaccine. Vaccine 38:47, pages 7414-7416.
Crossref
Kahren van Eer, Suzan Leussink, Tim T. Severs, Naomi van Marm-Wattimena, Petra J. Woestenberg, Johannes A. Bogaards & Audrey J. King. (2020) Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF 10 -DEIA-LiPA 25 (Version 1) Platform Compared to Type-Specific Real-Time Quantitative PCR Assays and Impact on Vaccine Effectiveness Estimates . Journal of Clinical Microbiology 58:11.
Crossref
Liqin Cheng, Johanna Norenhag, Yue O. O. Hu, Nele Brusselaers, Emma Fransson, Andreas Ährlund-Richter, Unnur Guðnadóttir, Pia Angelidou, Yinghua Zha, Marica Hamsten, Ina Schuppe-Koistinen, Matts Olovsson, Lars Engstrand & Juan Du. (2020) Vaginal microbiota and human papillomavirus infection among young Swedish women. npj Biofilms and Microbiomes 6:1.
Crossref
G. N. Minkina. (2020) Achievements and Prospects of Vaccination against Human Papillomavirus Infection and Associated Diseases. Epidemiology and Vaccinal Prevention 19:2, pages 110-118.
Crossref
Toon Braeye, Hanne-Dorthe Emborg, Ana Llorente-García, Consuelo Huerta, Elisa Martín-Merino, Talita Duarte-Salles, Giorgia Danieli, Lara Tramontan, Daniel Weibel, Chris McGee, Marco Villa, Rosa Gini, Matti Lehtinen, Lina Titievsky & Miriam Sturkenboom. (2020) Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries – The ADVANCE project. Vaccine 38:16, pages 3243-3254.
Crossref
Marcello Guido, Annarita Bruno, Luigi Tagliaferro, Valerio Aprile, Andrea Tinelli, Alberto Fedele, Giambattista Lobreglio, Paola Menegazzi, Giancarlo Pasanisi, Vittorio Tassi, Bruno Forcina, Francesca Fortunato, Laura Isabella Lupo & Antonella Zizza. (2020) Universal Human Papillomavirus Vaccination and its Impact on the Southern Italian Region. Current Pharmaceutical Design 26:3, pages 343-357.
Crossref
Karin Sundström & K. Miriam Elfström. (2020) Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?. PLOS Medicine 17:1, pages e1003035.
Crossref
Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, María Garcés-Sánchez, Nuria García Sánchez, Elisa Garrote Llanos, Ángel Hernández Merino, Antonio Iofrío de Arce, Manuel Merino Moína, Abián Montesdeoca Melián, María Luisa Navarro Gómez, Jesús Ruiz-Contreras, Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, María Garcés-Sánchez, Nuria García Sánchez, Elisa Garrote Llanos, Ángel Hernández Merino, Antonio Iofrío de Arce, Manuel Merino Moína, Abián Montesdeoca Melián, María Luisa Navarro Gómez & Jesús Ruiz-Contreras. (2020) Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2020. Anales de Pediatría 92:1, pages 52.e1-52.e10.
Crossref
Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, María Garcés-Sánchez, Nuria García Sánchez, Elisa Garrote Llanos, Ángel Hernández Merino, Antonio Iofrío de Arce, Manuel Merino Moína, Abián Montesdeoca Melián, María Luisa Navarro Gómez, Jesús Ruiz-Contreras, Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, María Garcés-Sánchez, Nuria García Sánchez, Elisa Garrote Llanos, Ángel Hernández Merino, Antonio Iofrío de Arce, Manuel Merino Moína, Abián Montesdeoca Melián, María Luisa Navarro Gómez & Jesús Ruiz-Contreras. (2020) IMMUNISATION SCHEDULE OF THE SPANISH ASSOCIATION OF PAEDIATRICS: 2020 RECOMMENDATIONS. Anales de Pediatría (English Edition) 92:1, pages 52.e1-52.e10.
Crossref
Rola Khamisy-Farah, Mohammad Adawi, Haneen Jeries-Ghantous, Jacob Bornstein, Raymond Farah, Nicola Luigi Bragazzi & Marwan Odeh. (2019) Knowledge of Human Papillomavirus (HPV), Attitudes and Practices Towards Anti-HPV Vaccination Among Israeli Pediatricians, Gynecologists, and Internal Medicine Doctors: Development and Validation of an Ad Hoc Questionnaire. Vaccines 7:4, pages 157.
Crossref
Silvia de Sanjose & Sinead Delany-Moretlwe. (2019) HPV vaccines can be the hallmark of cancer prevention. The Lancet 394:10197, pages 450-451.
Crossref
M. Vonsky, M. Shabaeva, A. Runov, N. Lebedeva, S. Chowdhury, J. M. Palefsky & M. Isaguliants. (2019) Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy. Biochemistry (Moscow) 84:7, pages 782-799.
Crossref
Elmar A. Joura, Maria Kyrgiou, Francisco X. Bosch, Vesna Kesic, Pekka Niemenen, Charles WE. Redman & Murat Gultekin. (2019) Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy. European Journal of Cancer 116, pages 21-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.